Logo1
2011 American Transplant Congress Meeting - Non-Physicians
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
Please rate the following:
The program was relevant to my work.
Content matched stated objectives.
Usefulness of handouts/AV.
Quality of facilities.
How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?
If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain:
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Objective 1: Provide a forum for exchange of new scientific and clinical information relevant to solid organ and tissue transplantation
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
Objective 2: Create an arena for the interchange of ideas regarding care and management of organ and tissue transplant recipients
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Objective 3: Facilitate discussions of the socioeconomic, ethical and regulatory issues related to solid organ and tissue transplantation
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Describe follicular helper T cells
Identify different types of memory B cells
Demonstrate how tt prevent chronic AMR by either method
Discuss the expression of  BLyS/BAFF family of receptors and ligands
Identify the role of BLyS and its receptors in B cell homeostasis and selection
Identify the role of BLyS in affinity maturation.
Distinguish between innate and adaptive immunity
Describe T cell positive and negative selection, enumerate T cell phenotypic subtypes, and explain homeostatic proliferation and its impact on T cell repopulation
Discuss the effects of emerging therapeutics on B cells and Plasma cells
Define different types of regulation.
Identify what different cell types can be involved in regulation
Review the specific experimental evidence for regulation in humans.
Outline the clinician's role and contribution toward a successful review
Discuss resource information for the OPTN/UNOS on-site tri-annual review process.
Discuss strategies for maintaining compliance with UNOS requirements
Discuss the issues involved in studying late graft dysfunction
Review use of serum biomarkers in diagnosis of acute & chronic renal allograft pathology
List the mechanisms of late organ transplant deterioration
Identify the difference between eligible and potential donors
Distinguish the organ-specific complications in DCD recipients
Discuss how discard rates have changed over time
Discuss the unacceptable rate of kidney discard the United States
Compare the experience of the United States to Europe
Describe the history upon which this unacceptable practice has developed
Identify the current technologies available for deep sequencing genomics
Distinguish between natural (thymic-derived) and peripherally induced T regulatory cells (Treg)
Identify mechanisms of action of polyclonal and antigen-specific T regulatory cells in vivo
Demonstrate basic concepts underlying adoptive cell therapy
List the pros and cons of the state of the art techniques to modify lymphocytes
Describe how ex vivo expanded T regulatory cells can be used to treat autoimmune disease
State the mechanisms by which grafts are injured during transplantation including ischemia-reperfusion and rejection
Describe mechanisms by which parenchymal cells of the graft undergo apoptosis and necrosis and mechanisms by which they resist injury
Evaluate upcoming strategies by which graft injury may be modified
Describe the rationale for failed transplant
Discuss the issues involved in studying late graft dysfunction
Review use of NMR spectroscopy in diagnosis of acute & chr
Review survival after transplant failure
Review pros and cons of immunosuppressant withdrawal
Discuss an approach to use of  immunosuppressant medication after transplant failure
Identify tools used in a transplant quality assurance and process improvement programs
Outline key documentation requirements
Describe the purpose of the program specific reports and how to use them
Decscribe the rationale for normothermic ex vivo lung perfusion (EVLP)
Identify unique challenges in procurement as it relates to VCA, unique challenges in hand transplants; unique challenges in face transplants.
Describe specific examples of the value of donor registries in the context of organ donation
Describe the rationale for normothermic ex vivo lung perfusion (EVLP)
Demonstrate the technique of perfusion and assessment of injured donor lungs
Identify which donor lungs need EVLP and when a lung is good to transplant after EVLP
Discuss the design, enrollment and conduct of clinical trials in pediatric transplantation
Identify the evolving role of steroids in pediatric transplantation
Summarize drug minimization protocols
Create a framework for promoting communication between the Immunogenetics
Discuss the combination of immunosuppression medications in common protocols
Discussion of strengths, weaknesses and future applications of transcriptomics 
Identify the differences in the frequency of tolerance for different transplanted organs and how these differences drive the design of tolerance studies.
Discuss the potential biomarkers of tolerance and understand how these may differ for different transplanted organs.
Describe the potential regulatory role of B cells in immunity and transplantation tolerance.
Discuss the spectrum of transplant research.
Identify the relevant pathways involved in immune management of transplant patients.
Discuss research interests.
Define functional immmune tolerance in humans
List 3 assays that measure immune responsiveness and regulation
Describe the utilization of a "Fire Drill" to aid in survey readiness
Discuss and understand differences between processes and vision. 
Identify issues faced by transplant center to establish compliance.
Discuss the scope and basic components of the 2007 CMS Transplant Center COP
Discuss the alignment of the Tx Center COP with known quality principles such as those defined by Donabedian and the concepts of high reliability
Discuss the difference in focus in the second round of center surveys and how to prepare for them.
Identify common surgical complications in kidney transplantation.
Discuss the impact that acute rejection plays in the survival of transplants and transplant recipients.
Explore methods by which nephrotoxicity can be minimized.
Define prevalence of anemia after sucessful transplantation
Discuss the causes of anemia post-transplant
Discuss the pros and cons of using ESAs in this population
Describe current tolerance protocols
Identify the risks and benefits of alemtuzumab induction for renal
Identify metabolic benefits in terms of severity of diabetes from recent randomized trials.
Identify dermatologic findings as signs of systemic infection in immunocompromised patients
Identify emerging methods for identification of respiratory viral infections in transplant recipients
Classify the disease burden associated with infection with HHV-6 and HHV-7
Design a management plan to reduce the risk of acute kidney injury
 Describe the major cardiopulmonary pathologies associated with liver cirrhosis and portal hypertension
Describe the critical care management of acute liver failure
Recite the current general concepts of anesthesia for liver transplantation
Practice hemodynamic management.
Practice coagulation management
Discuss how a viral infection might trigger graft injury or rejection
List information about the technologies and platforms to measure gene expression profiles
List examples of applications of gene expression profiling in organ transplantation
List the current technologies availabe for deep sequencing genomics
Name advantages and disadvantages of the different technologies
State what kind of transplantation problems can be addressed using these technologies
Identify the importance of the Cost Report
Identify main items to check
Prepare documentation for cost recoveries
Identify the criteria of acute liver rejection diagnosis and management.
Apply into practice the advances in therapeutic management.
Discuss strategies for prevention of early infections following liver transplantation and their limitations
Review common surgical complications after liver transplantation.
Review therapeutic interventions required for surgical complications.
Describe short and long-term sequelae of surgical complications.
Discuss the safety and efficacy of solid organ transplantation in people infected with HIV.
State the complex pharmacokinetic interactions between immunosuppressive medications and anti-retroviral medications.
Identify the risks of co-infection with HIV and hepatitis C in outcomes following liver and kidney transplantation.
Discuss HIV transplantation and follow-up the same everywhere in the world.
Identify what makes HIV positive to positive transplantation viable in South Africa.
Identify the implications and dangers of utilizing HIV positive kidneys for transplantation.
Define the role of effector CD8+ T cells in organ transplantation
Identify the role of CD8+ effector T cells in tolerance induction.
Discuss potetnial development of the regimen focusing on inihibition of CD8+ effector/memory Tcell
Discuss the evolution of current REMS legislation
Discuss the application of REMS in organ transplantation
Describe the risks and benefits of generic immunosuppressant utilization
Discuss current mandates requiring dedicated pharmacy services on transplant teams
Compare and contrast inpatient versus outpatient pharmacy services
Identify the impact of outpatient pharmacy services on level of billing and reimbursement
Describe KDRI and how it relates to post-transplant survival
Utilize KDRI to better understand the current rate of 2700 discarded kidneys
Identify protective endothelial genes are expressed under pulsatile perfusion  
Review preservation of graft quality is possible with in situ perfusion.
Describe reduction of metabolic rate is essential
Describe repair mechanisms can be stimulated in the brain dead donor
Discuss the impact of respiratory viruses following lung transplantation.
Review potential therapies for treating acute respiratory viral infection following lung transplantation, and preventing subsequent allograft injury secondary to these viruses.
Discuss the epidemiology of respiratory viral infections in SOT recipients
Define Heterologous Immunity
Discuss the interplay between Heterologous Immunity and allo-reactivity
Discuss the impact of donor-reactive memory on graft survival
Identify Pathogensesis of chronic viral infection - role of memory/effector and regulatory T Cells
State new strategy in managing immunosuppression after transplantation
List the results from the first in human trial that used expanded T regulatory cells to prevent GVHD
Discuss human immunosenescence and the age-associated changes to immune parameters enabling this to be measured
Describe the contribution of chronic antigenic stress to ageing of the human immune systgem
Identify role of persistent viral infections, especially with HHV5 (Cytomegalovirus) in human immunosenescence
Define immune tolerance in clinical transplantation.
Discuss the reasons for pursuing tolerance induction versus  conventional immunosuppression
Identify current limitations of this strategy
Define immune tolerance in clinical transplantation.
Describe the status of a current trial of tolerance induction in clinical kidney transplantation
Utilize the technique of tolerance induction used in this trial
Describe the clinical course of acute tubular injury
Describe the current indications for double kidney transplantation
Discuss the long term outcome of double transplants
Describe the clinical course of acute tubular injury
Evaluate deceased donors with acute tubular injury
Discuss the post-transplant course of recipients that receive kidneys from donors with acute tubular injury.
Discuss the concept of rebalanced hemostasis in patients with cirrhosis.
Identify the mechanisms of hypercoagability in end stage liver disease
Discuss the mechanisms of increased bleeding tendency in end stage liver disease
Describe the purpose of surrogate endpoints
Evaluate a method for evaualating the strength of surrogate endpoints
Identify alternative strategies from trials that use common surrogate endpoints
Discuss the differences in outcomes of pregnancies in the different types of solid-organ transplant recipients.
Discuss current contraceptive options for the transplanted woman
Discuss available data regarding pregnancy in transplant recipients
Review pre-conception counseling guidelines for female transplant recipients
Discuss the differences in outcomes of pregnancies in the different types of solid-organ transplant recipients.
Discuss strategies for counseling and management of pregnancy in female transplant recipients
Disease State Management/Drug Management therapy
Discuss the magnitude of variation in organ availability in different areas of the country.
Describe the effect of this variation on the outcome of liver transplantation.
List the causes of geographic variation in organ availability and how the system compensates.
Discuss how B cells and plasma cells are consistent findings in and around coronary arteries with allograft vasculopathy.
Demonstrate that these cells are found most frequently in nodules, some of which are compartmentalized and contain follicular dendritic cells (FDCs) that typify tertiary lymphoid nodules.
Debate that perivascular fat, once considered merely a storage tissue is an abundant source of cytokines
Discuss the expression of  BLyS/BAFF family of receptors and ligands
Describe the role of BLyS and its receptors in B cell homeostasis and selection
Discuss the role of BLyS in affinity maturation
Identify the current technologies available for deep sequencing genomics
Discuss the advantages and disadvantages of the different technologies
Define biomarkers and surrogate markers
List 5 candidate biomarkers for acute and or chronic injury to an allograft
Explain the utility of biomarkers as modalities to guide therapuetic decision making
Discuss the controversy concerning the origin of scar-forming myofibroblasts in chronic kidney disease
Describe the role of T cells in certain types of lung fibrosis.
Identify the functions of Th17 cytokines, especially IL-22, and its potential role as a therapeutic modality.
Discuss the controversy concerning the origin of scar-forming myofibroblasts in chronic kidney disease
Discuss the power of genetic lineage analysis to track cell fate in vivo in mouse kidney disease models
Review new data that indicates that EMT (Epithelial to Mesenchymal Transition) does not contribute to renal myofibroblasts, but rather resident pericytes/fibroblasts are the myofibroblast precursor population
Examine the options for use of thrombolytic agents in DCD liver transplantation
Review the preliminary single center data on the comparison of the use of thrombolytic agents to not using them with respect to graft function and blood utilization
Review the rationale for the use of thrombolytic agents in DCD livers
Identify outcomes of liver transplantation with DCD organs - the learning curve
Identify who is the ideal recipient for a DCD liver
Discuss implications of the development of Ischemic cholangiopathy - quality of life measures and cost
Review the relevance of memory T cells in Transplantation
Discuss strategies to control donor-reactive memory T cell responses
Describe the use of combined biologics to induce operational tolerance
Identify immunosuppressive properties of costimulatory blockers (CB).
Identify drug combinations with CB.
Discuss clinical development of CB
Define expected outcomes with DAAs in non-transplant patients
Identify key management issues for use of DAAs in transplant recipients
Discuss side effects, adverse reactions, and viral resistance
Identify the risk factors for EBV and BK infections
Describe the varied disease manifestations of these infections
Describe the need to monitor for infectious disease outcomes even if this is not primary study endpoint
Review the 2nd edition of the Infectious Disease Guidelines with a focus on major topics.
Review the major pediatric updates in guideline #2.
Identify pediatric areas in need of further research.
Describe differences and similarities between rejction of xenogeneic and allogeneic organs
Identify the infectious risks of xenotransplantation
Describe the infectious risks of human allotransplantation
Describe differences and similarities between rejction of xenogeneic and allogeneic organs
Discuss the concept of accommodation
Describe the mechanisms of interaction between antibodies and endothelial cells
Identify the options vailable to highly sensitized patients
Describe the limitations of solid phase HLA antibody detection assays.
Discuss findings in molecular and –omics studies that relate to AMR
Identify antibody identification techniques
Describe the role of kidney paired donation in transplanting the recipient with an incompatible donor
Explain the potential of single center KPD programs
Describe pioneering research within the field of transplantation
Discuss the indications and contraindications for heart and lung transplantation.
List available data sources, accessibility, cost
Compare outcomes forpancreas after kidney transplantation compared to simultaneous pancreas and kidney transplantation
Discussion of allocation as it applies to pancreas after kidney transplantation compared to simultaneous pancreas and kidney transplantation.
Identify the differences between the low- and high-risk recipients factors influencing outcomes
Discuss how B cells and plasma cells are consistent findings in and around coronary arteries with allograft vasculopathy.
Describe the differences in the frequency of tolerance for different transplanted organs and how these differences drive the design of tolerance studies
Discuss potential biomarkers of tolerance and understand how these may differ for different transplanted organs.
Discuss how B cells and plasma cells are consistent findings in and around coronary arteries with allograft vasculopathy.
Demonstrate that these cells are found most frequently in nodules, some of which are compartmentalized and contain follicular dendritic cells (FDCs) that typify tertiary lymphoid nodules.
Debate that perivascular fat, once considered merely a storage tissue is an abundant source of cytokines
Review the quality metrics used in other reviews of medical intervention.
Describe new evaluation tools in use and being developed by OptumHealth
Describe newly developing concept of value - not just one year patient and graft survival anymore.
Identify what the future holds regarding the oversight of quality in transplant centers
Discuss how The Joint Commission will approach the evaluation of transplant center performance begining in 2012
Discuss how Joint Commission transplant center certification will be coordinated with CMS and UNOS
Discuss the T cell response pathway and its relevance to transplantation
Identify the potential and goals of a national KPD Program.
Compare the merits of a national program when compared to regional and local systems.
Discuss the T cell response pathway and its relevance to transplantation
Describe immunosuppression agents and their mechanisms of action
Discuss the relevance of these mechanisms to transplantation
Discuss the principles and current standards of immunosuppressive therapy in CTA
Review current Banff classifications for VCA skin rejection.
Identify pros and cons of immunosuppression minimization protocols in CTA
Report data on validation of Banff scoring for VCA.
Review current Banff classifications for VCA skin rejection.
Discuss tissue pathology of VCA associated with vasculopathy and deep tissue changes in non-human primate model
Describe the possible implications of donor selection, liver biopsy and immunosuppression in HCV post LT.
Discuss the current post-transplant HCV therapy options
Identify future post-transplant HCV therapies and potential concerns.
Identify physiological differences between immunosuppression agents on HCV biology
Discuss associations of primary and induction immunosuppression and posttransplant outceoms in patients with HCV
Indicate possible drug interactions between immunosuppression agents and antivirals
Identify the problem of donors without insurance
Integrate an improved individualized risk assessment model
Identify gaps in provisions for donors, as well as expected impact of Affordable Care Act
Identify what the current general demographics of living donors are
Discuss what the current health care coverage of living donors is.
Identify what the current frequency of minor medical abnormalities are
Explain HV outflow
Explain HV inflow
Identify BD Anastmosis
Review risk factors for new onset diabetes after transplantation (NODAT), discuss pathogenesis and modification/management of NODAT
Discuss how the immune system changes with age
Describe the allocation of older organs
Discuss mortality rates for older transplant recipients
Explain the role of IL 17 in acute and chronic rejection and resistance to tolerance
List the biology of IL 17
Develop strategies and exchange ideas
Identify the role of ECMO in the support of patients with heart or lung failure awaiting transplant
 Describe the use of ECMO as a bridge to recovery, impact of changes in technology in improving patient outcomes
Discuss the next generation of ideas for heart failure including
Report autologous cell types available for recellularizing organs
Utilize the efficacy of those cell types for organ recellularization
Identify the general and specific risks associated with living donor hepatectomy
Describe the pathogenesis of small-for-size syndrome
Describe techniques to decrease portal flow
Identify the general and specific risks associated with living donor hepatectomy
Review the strategies that may attenuate these risks
Describe the long term outcomes of live liver donation
Describe the impact of rATG on T cell phenotypes in adults post renal transplantation
Describe the impact of rATG on T cell phenotypes in children post renal transplantation
Describe the effect of rATG on regulatory T cells post renal transplantation
Discuss T cell memory
Identify homeostatic proliferation
Describe why they are barriers to tolerance
Define microRNAs and how they regulate gene expression
Describe how alteration of microRNA activities participate in disease formation
State examples of how modulating microRNAs and their regulated pathways might be used therapeutically
Develop an understanding of microRNA biogenesis
Identify  the role of microRNA in kidney injury
Identify the role of microRNA in transplants. 
List the current status of human islet isolation and transplantation techniques
Explain the advances of treatment strategies for transplantation of adult human insulin-producing cells in the most severe cases of type 1 diabetes
Explain the progress of current prospective randomized multicentertrials of islet transplantation that are part of the NIH-sponsored Clinical Islet Transplantation Consortium
Discuss the rationale for the three different approaches to antiviral therapy in the liver transplant setting (antiviral therapy pre-transplantation, preemptive antiviral therapy, treatment of established graft disease
Describe the importance of prevention of HBV re-infection in achieving good outcomes after liver transplantation
Analyze the diagnosis and management of hepatitis C virus in non-hepatic organ recipients
Describe methods of assessing immunologic function in long-term survivors of heart transplantation
List the most common viral, fungal, and bacterial infections that occur in long-term survivors of heart transplantation
Discuss preventive measures to help decrease infection risk in the long-term heart transplant recipient
Identify the pathophysiology of and factors that contribute to the development of cardiac allograft vasculopathy.
Discuss various approaches used to try to prevent or ameliorate cardiac allograft vasculopathy experimentally and the underlying immunologic justification for these approaches.
Discuss the results of recent clinical trials directed at preventing cardiac allograft vasculopahy and how they may impact clinical practice in the future.
Discuss how immunosuppression choices impact pancreas tx outcomes in the pancreas-after-kidney tx recipient.
Create strategies to improve results of pancreas-after-kidney transplant results
Identify the factors that contribute to quality of life after LT.
Discuss the results of pancreas transplantation as it pertains to the various options vis-a-vis simultaneous pancreas-kidney tx and pancreas-after-kidney transplantation.
Describe how immunosuppression choices impact pancreas tx outcomes in the pancreas-after-kidney tx recipient.
Create strategies to improve results of pancreas-after-kidney transplant results.
Review mechanisms of immune tolerance
Define the role of T cell anergy as it relates to peripheral tolerance
Diagnose the tolerance and loss of tolerance
Identify one biomarker in diagnosing rejection in heart transplant recipients.
Define Evidence-based practice (EBP)
Discuss examples of evidence-based projects to improved transplant outcomes
Discuss the role of biomarkers
Identify one biomarker in diagnosing rejection in heart transplant recipients.
Discuss one biomarker for rejection in lung transplant recipients.
Identify  the indications for pump and pumpless extracorporeal life support
Describe how illness can favor and disfavor candidates
Identify criteria that may be relaxed in the setting of a critically ill candidate
Discuss  the options to bridge patients to lung transplantation
Identify  the indications for pump and pumpless extracorporeal life support
Describe the impact of extracorporeal life support on waiting list mortality and outcome
Discuss current patterns of utilization of high risk organs in the United States
Discuss process of informed consent for potential recipients.
Review outcomes with use of high risk donors.
Discuss current patterns of utilization of high risk organs in the United States
Describe potential factors that may be associated with use or non-use of high risk organs
Report potential opportunities to increase transplant rates through utilization of high risk organs
Describe and give examples of cross-sectional and longitudinal outcomes for solid organ transplant clinical trials.
Interpret graphical presentations of longitudinal outcomes.
Analyze the basic ideas, and some of the terminology, of analyses of longitudinal outcomes, which is the first step in establishing effective communications with their local, biostatisticians for using these methods for clinical research.
Describe the complement system.
Identify how small molecules can be used to control intracellular protein 
Discuss approaches for re-purposing existing drugs for new applications
Describe the complement system.
Discuss the role of the complement system in inflammation in transplantation
Discuss potential complement inhibitory strategies
Identify types of infections seen with newer biologics
Describe infectious complications (including post-transplant lymphoproliferative disease) associated with the use of belatacept in investigational clinical trials conducted in support of FDA acceptance of this biologic agent.
Design study tools to use for infectious disease monitoring
Identify types of infections seen with newer biologics
Discuss the importance in increase awareness of need for reporting
Identify ways to mitigate the risk of infection
Explain what alloreactive memory T cells are
Discuss strategies to prevent homeostatic expansion of memory T cells and prevent rejection mediated by memory T cells.
Define biomarkers and surrogate markers
Explain what alloreactive memory T cells are
Explain how memory T cells influence the alloresponse and allograft rejection
Report whether alloreactive memory T cells influence tolerance induction
Report current options for local-regional therapy for HCC
Describe the molecular classifications of HCC that are emerging from large-scale molecular profiling experiments
Identify the role of resection in treatment of HCC
Discuss current options for local-regional therapy for HCC
Discuss how key molecular pathways are being identified that may provide new targets for therapy of HCC.
Discuss the role of transplant in treatment of HCC
Define biomarkers and surrogate markers
List 5 candidate biomarkers for acute and or chronic injury to an allograft
Discuss practical application to clinical transplantation
List new tissue analysis techniques for biopsy analysis.
Describe methods of multiplex staining, whole slide imaging, and image analysis
Discuss potential application of these newer techniques for research and clinical care.
Discuss role of ECMO in the support of patients with heart or lung failure awaiting transplant
Review ECMO as a bridge to recovery, impact of changes in technology in improving patient outcomes
Discuss barriers to the use of pediatric donor kidneys
State results associated with pedi donor kidney transplantation
Identify the best utilization of resources
Summarize the field of Tissue Engineering and Regenerative Medicine.
Discuss the relevance to Transplantation.
Identify barriers to success.
List biomarkers that have been evaluated in solid organ transplantation and had demonstrated potential clinical utility in predicting/diagnosing overimmunosuppression, organ toxicity, and acute or chronic rejection
Identify gaps or areas of biomarker discovery and development that could be addressed further to improve outcomes in the transplant patient
Discuss the benefits and challenges of drug/diagnostic co-development.
Discuss the variety of relationships between donor and recipient and their potential impact on quality of life
Identify the relapse rates to alcohol use following liver transplant for alcohol related liver disease.
Identify 3 core strategies for reducing drug-seeking behavior by patients post-transplant.
Discuss the variety of relationships between donor and recipient and their potential impact on quality of life
Describe the concept of informed consent in the context of living donor transplanation
Explore potential ethical problems that may arise in living donor transplantion.
Define biomarkers and surrogate markers
Discuss what a CoP is and specifically, the Trainee and Junior Faculty CoP
Describe the use of combined biologics to induce operational tolerance

Discuss the outcomes with the current generation of mechanical circulatory support (MCS)

Describe methods for detecting de novo antibodies after transplantation
Discuss the histological lesions in kidney allograft biopsies and their prognostic significance
Explain the difference between diagnostic and prognostic significance of histopathological lesions
Describe methods for detecting de novo antibodies after transplantation
Discuss the incidence of de novo antibodies in a multicenter study
Demonstrate the effect of de novo antibodies on renal allograft outcomes
Identify the post renal transplant bone loss results from a spectrum of disorders and that treatment should be targeted to the underlying disorder
List the indications for treatment with bisphosphonates and teriparatide to treat bone loss
Summarize the indications for bone
Identify hemodynamic instability during brain death
List the contents the Consensus Statement.
Design study tools to use for infectious disease monitoring
Identify hemodynamic instability during brain death
Identify organ dysfunction of the organ donor
Discuss resuscitation and management of the organ donor
Discuss the indications for intestine transplantation
Summarize the need for specialized care for patients with intestinal failure prior to transplantation
Discuss the potential for changes in timing and indications for intestine transplant as a result of the current emphasis on multidiscplinary intestinal failure care
Identify specific rare progenitors settle the thymus to give rise to T cells.
Discuss MSC source, phenotype and expansion
Discuss immunological mechanisms related to allograft rejection and tolerance induction
Identify specific rare progenitors settle the thymus to give rise to T cells.
Describe the molecular basis  of this specificity
Discuss how homing to the thymus is limiting after bone marrow transplant.
Describe the incidence of acute cellular rejection after heart transplantation and the current modalities for rejection surveillance.
Identify appropriate candidates for gene expression testing to monitor for acute cellular rejection
Summarize the current and future application of gene expression profiling in the management of heart transplant recipients.
Describe what is meant by systems and processes of care
Discuss examples of safety issues related to transplantation
Develop different methodologies to assess near misses, medical errors and adverse events
Identify principles and types of bio-artificial liver support.
Describe Limitations of bio-artificial liver support
Discuss current and future applications for BAL technology.
Discuss the procurement issues, from an OPO perspective, that are crucial to the VCA donation process.
Identify potential issues with allocation and regulation of VCAs
Discuss the primary issues that a VCA transplant program MUST collaborate with its local Organ Procurement Organization on.
Identify arguments for allocation of organs
Discuss what policies are ethically acceptable in the drive to obtain organs
Discuss what ethical challenges await as the field expands toward composite transplants
Review advances in transplantation in the past year
Discuss current research techniques
Evaluate new data

Name the populations in which transplant may have less than ideal outcomes

Identify outcomes in high risk transplant population to outcomes with MCS

Identify patients pre-transplant/post-transplant who are at high risk for skin cancer by understanding the main risk factors for development of skin cancer in these patients.
Identify the appearance of precancerous/cancerous change of the skin.
Plan effective antihypertensive drug therapy for the long-term after transplantation
Please answer the following:
Do you believe this activity was appropriate for the scope of your professional activities?
Was the educational content scientifically sound?
Was the educational content free of commercial bias?
Was the mode of education effective to learning?
If you answered "No" to any of the above questions, please explain.
Were you solicited by sales personnel in an educational room while you attended this educational activity?
If you answered "Yes" to the above question, please explain.
What did you learn during this activity that you intend to integrate into your practice?

What questions have arisen in your practice for which you need answers/strategies that you can implement?

What patient problems or patient challenges do you feel you are not able to address appropriately or to your satisfaction?
What problems are your patients communicating to you that need attention or follow up?

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training (the overall meeting) be improved to better impact competence, performance and/or patient outcomes?

Additional comments:

Mr question